Intake questionnaire
Atezolizumab + Sacituzumab Govitecan to Prevent Recurrence in TNBC (ASPRIA)
Applying to Vanderbilt-Ingram Cancer Center · Nashville, Tennessee
Answer a few short questions to share with the research team.
0 of 4 answered
Intake questionnaire
Applying to Vanderbilt-Ingram Cancer Center · Nashville, Tennessee
Answer a few short questions to share with the research team.
0 of 4 answered